| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/02/2002 | CA2214909C New topical compositions in the form of o/w liquid emulsion with a high pro-penetrating glycol content |
| 07/02/2002 | CA2201163C Utilization of an extract of at least one iridacea in the treatment of wrinkles |
| 07/02/2002 | CA2152487C Method for treating a medical patient for cardiac trauma |
| 07/02/2002 | CA2123696C Antitumor vaccines |
| 07/02/2002 | CA2061703C Formulations containing hyaluronic acid |
| 07/02/2002 | CA1341373C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 06/27/2002 | WO2002050115A1 Modified tachykinin receptors |
| 06/27/2002 | WO2002050097A2 Anti-allergic complex molecules |
| 06/27/2002 | WO2002050089A1 Method for purification of lactose |
| 06/27/2002 | WO2002050001A2 Non-halogenated naphthol compounds and antimicrobial compositions containing the same |
| 06/27/2002 | WO2002049771A1 Electrostatic application of powder material to solid dosage forms in an electric field |
| 06/27/2002 | WO2002049676A2 Compositions containing inclusion complexes |
| 06/27/2002 | WO2002049660A1 Injectable solution with anti-inflammatory effect and process for manufacturing the same |
| 06/27/2002 | WO2002049658A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/27/2002 | WO2002049654A1 Shark meat extract |
| 06/27/2002 | WO2002049652A1 Method of treatment |
| 06/27/2002 | WO2002049646A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 06/27/2002 | WO2002049645A1 Therapeutic combination of amlodipine and benazepril |
| 06/27/2002 | WO2002049638A1 Medicinal granular preparation containing branched amino acids |
| 06/27/2002 | WO2002049637A1 A novel soft-gelatin capsule comprising s-adenosylmethionine and a method for producing the same |
| 06/27/2002 | WO2002049636A1 An antidiabetic composition of amino acids |
| 06/27/2002 | WO2002049631A1 Propofol formulation with enhanced microbial inhibition |
| 06/27/2002 | WO2002049624A2 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists |
| 06/27/2002 | WO2002049623A2 Adhesive label with fluidifying agents for natural airway secretions |
| 06/27/2002 | WO2002049622A2 Transdermal system containing a novel high potency progestagen |
| 06/27/2002 | WO2002049621A1 Enteric-coated drug formulations and their manufacture |
| 06/27/2002 | WO2002049620A2 Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 06/27/2002 | WO2002049619A2 Induced phase transition method for the production of microparticles containing hydrophilic active agents |
| 06/27/2002 | WO2002049618A1 Amoxycillin pellets |
| 06/27/2002 | WO2002049617A2 Self forming, thermodynamically stable liposomes and their applications |
| 06/27/2002 | WO2002049616A1 Pharmaceutical aerosol formulation |
| 06/27/2002 | WO2002049615A2 Artificial tear composition containing a combination of three demulcents |
| 06/27/2002 | WO2002049614A2 Intraocular irrigating solution having improved flow characteristics |
| 06/27/2002 | WO2002049613A2 Method for enhancing integrity of epithelium using retinoic acid |
| 06/27/2002 | WO2002049612A2 Hypertonic ophthalmic irrigation solution adapted for use in lasik surgery |
| 06/27/2002 | WO2002049611A2 Ophthalmic lubricating solution adapted for use in lasik surgery |
| 06/27/2002 | WO2002049610A2 Ophthalmic irrigating solution adapted for use in lasik surgery |
| 06/27/2002 | WO2002049609A1 Ionophore antibiotic formulations |
| 06/27/2002 | WO2002049608A1 Cabergoline pharmaceutical compositions and methods of use thereof |
| 06/27/2002 | WO2002049607A2 Flavoured oral drug delivery system |
| 06/27/2002 | WO2002049606A2 Transdermal systems (tds) that contain inhibitors of phosphodiesterase iv |
| 06/27/2002 | WO2002049603A1 Compositions for prevention and alleviation of skin wrinkles |
| 06/27/2002 | WO2002049578A1 Remineralising dental adhesive film |
| 06/27/2002 | WO2002049573A2 Novel in-situ forming controlled release microcarrier delivery system |
| 06/27/2002 | WO2002049571A2 Personal medication dispensing card |
| 06/27/2002 | WO2002049557A1 Method for the prevention, inhibition, or treatment of vaginitis and/or bacterial vaginosis using polystyrene sulfonate |
| 06/27/2002 | WO2002049552A2 Solution for removing cataracts via liquefracture |
| 06/27/2002 | WO2002049501A2 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | WO2002034232A3 Use of carotenoids for treating ageing symptoms |
| 06/27/2002 | WO2002034231A3 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid |
| 06/27/2002 | WO2002030393A3 Polymeric delivery formulations of leuprolide with improved efficacy |
| 06/27/2002 | WO2002030390A3 Method for producing powdery formulations |
| 06/27/2002 | WO2002020073A3 Devices, systems and methods for patient infusion |
| 06/27/2002 | WO2002019988A3 Sustained release particle dispersion |
| 06/27/2002 | WO2002017928A3 Transdermal therapeutic system for releasing exemestane |
| 06/27/2002 | WO2002015881A3 Use of a porous carrier |
| 06/27/2002 | WO2002009704A3 Pharmaceutical composition for transdermal delivery of befloxatone |
| 06/27/2002 | WO2002007672A3 A medicinal aerosol formulation |
| 06/27/2002 | WO2002002182A3 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system |
| 06/27/2002 | WO2002002082A3 Use of dicalcium phosphate anhydride powder |
| 06/27/2002 | WO2002000196A3 Wet milling process |
| 06/27/2002 | WO2001097788A3 Method of administering bisphosphonates |
| 06/27/2002 | WO2001096286A3 Urokinase inhibitors |
| 06/27/2002 | WO2001093853A8 Management of snoring by oral administration of dimethyl sulfone |
| 06/27/2002 | WO2001081182A3 Improved method and apparatus for generating an aerosol |
| 06/27/2002 | WO2001074330A3 Method for treating dry eye |
| 06/27/2002 | WO2001040182A3 Solid pharmaceutical preparation |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2000050008A9 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 06/27/2002 | US20020082745 Method and system for producing customized cosmetic and pharmaceutical formulations on demand |
| 06/27/2002 | US20020082620 Bioactive materials for aneurysm repair |
| 06/27/2002 | US20020082583 Method and device for enhanced delivery of a biologically active agent through the spinal spaces into the central nervous system of a mammal |
| 06/27/2002 | US20020082581 Valve for aerosol container |
| 06/27/2002 | US20020082417 Compound for use in the treatment of vision defects and chronic obstructive pulmonary diseases |
| 06/27/2002 | US20020082373 Fluid thickeners comprising neutralized crosslinked polymers of acrylamidoalkylsulonic acids and N-vinylamides |
| 06/27/2002 | US20020082307 Useful for therapy of symptoms associated with respiratory illnesses |
| 06/27/2002 | US20020082306 Heating aqueous solution of polyoxyethylene-660-hydroxystearate, adding beta-carotene with stirring; adding ascorbyl palmitate and alpha-tocopoherol as antioxidant to solution; diluting with water |
| 06/27/2002 | US20020082305 Petrolatum-based nose ointment |
| 06/27/2002 | US20020082304 Containing combination inhibitor, combination inhibitor which acts both to interfere with the isolation of sympathomimetic amine from the composition and to interfere with conversion of sympathomimetic amine to another drug |
| 06/27/2002 | US20020082301 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 06/27/2002 | US20020082299 Administering a given dosage of creatine |
| 06/27/2002 | US20020082291 New use of taxoid derivatives |
| 06/27/2002 | US20020082279 Topical mixture of a carrier, essential oil, and a conventional dermatologic active ingredient |
| 06/27/2002 | US20020082251 Desmethylolanzapine compositions and methods |
| 06/27/2002 | US20020082238 Delivering nucleic acids to vascular smooth muscle cells which line a wall of the blood vessel and energizing the transducer to deliver vibrational energy to the wall at a frequency and intensity selected to enhance uptake of nucleic acids |
| 06/27/2002 | US20020082237 Complexing a cationic polymer and/or cationic lipid with a polynucleotide in the presence of detergent, removing the detergent whereby a stable polynucleotide dellivery vehicle is produced |
| 06/27/2002 | US20020082230 Introducing an antisense oligomer into a cell, allowing the oligomer to hybridize to the mRNA of IL-15, thereby inhibiting the production of IL-15 |
| 06/27/2002 | US20020082221 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing S-N=O, N-N=O or |
| 06/27/2002 | US20020082201 And pharmaceutically acceptable surfactant including sodium lauryl sulfate, buffering agent to provide pH of 3.0-7.0, 0.5-10.0 weight percent colloidal silicon dioxide |
| 06/27/2002 | US20020082199 Insoluble insulin compositions |
| 06/27/2002 | US20020082198 Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 06/27/2002 | US20020081739 Genetically engineering cells; obtain cell, obtain nucleotide sequences, adhere sequences to sheets, propel sheet into cells, recover transformed cells |
| 06/27/2002 | US20020081729 Nutrient broth for propagating cellss |
| 06/27/2002 | US20020081556 Sustained-release matrices for dental application |
| 06/27/2002 | US20020081430 Chitosan microflake |
| 06/27/2002 | US20020081411 Storage wrap material |
| 06/27/2002 | US20020081339 Biodegradable microspheres releasing an anticancer agent are injected into the tumor, into the peritumoral area or both at the same time |
| 06/27/2002 | US20020081338 Composition for treating dry eye |
| 06/27/2002 | US20020081336 Parenterally administrable microparticles |
| 06/27/2002 | US20020081335 Method and apparatus for forming composite pellets for the controlled release of the active ingredient in the treatment of humans or animals and composite pellets thereof |